Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis

NCT02705625 is registered in ClinicalTrials.gov with Medivir as lead sponsor.

NCT NCT02705625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02705625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis
Lead sponsor
Medivir
Phase
Phase 2
Overall status
Completed
Start date
January 28, 2016
Completion date
May 23, 2017
Enrollment
244 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee